Active Ingredient History
Ripasudil, a derivative of fasudil, is a rho kinase inhibitor drug used for the treatment of glaucoma and ocular hypertension. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Corneal Diseases (Phase 2)
Corneal Endothelial Cell Loss (Phase 2)
Fuchs' Endothelial Dystrophy (Phase 4)
Glaucoma, Open-Angle (Phase 3)
Ocular Hypertension (Phase 3)
Retinopathy of Prematurity (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue